Allogeneic Hematopoietic Cell Transplantation in Patients With Myelodysplastic SyndromesPLATZBECKER, Uwe.Seminars in hematology. 2012, Vol 49, Num 4, pp 342-349, issn 0037-1963, 8 p.Article

Chelerythrin activates caspase-8, downregulates FLIP long and short, and overcomes resistance to tumour necrosis factor-related apoptosis-inducing ligand in KG1a cellsPLATZBECKER, Uwe; WARD, Jessica L; DEEG, H. Joachim et al.British journal of haematology. 2003, Vol 122, Num 3, pp 489-497, issn 0007-1048, 9 p.Article

CD34⁺-enriched peripheral blood progenitor cells from unrelated donors for allografting of adult patients: high risk of graft failure, infection and relapse despite donor lymphocyte add-backBORNHÄUSER, Martin; PLATZBECKER, Uwe; THEUSER, Catrin et al.British journal of haematology. 2002, Vol 118, Num 4, pp 1095-1103, issn 0007-1048Article

The graft content of donor T cells expressing γδTCR⁺ and CD4⁺foxp3⁺ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donorsPABST, Caroline; SCHIRUTSCHKE, Holger; EHNINGER, Gerhard et al.Clinical cancer research. 2007, Vol 13, Num 10, pp 2916-2922, issn 1078-0432, 7 p.Article

Second donation of granulocyte-colony-stimulating factor-mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cellsPLATZBECKER, Uwe; BORNHÄUSER, Martin; ZIMMER, Kristin et al.Transfusion (Philadelphia, PA). 2005, Vol 45, Num 1, pp 11-15, issn 0041-1132, 5 p.Article

Treatment of Chronic Steroid-Refractory Graft-Versus-Host Disease With Low-Dose RituximabVON BONIN, Malte; OELSCHLDGEL, Uta; RADKE, Jörgen et al.Transplantation. 2008, Vol 86, Num 6, pp 875-879, issn 0041-1337, 5 p.Article

Successful eradication of acquired factor-VIII-inhibitor using single low-dose rituximabWERMKE, Martin; VON BONIN, Malte; GEHRISCH, Siegmund et al.Haematologica (Roma). 2010, Vol 95, Num 3, pp 521-522, issn 0390-6078, 2 p.Article

Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDSJOACHIM DEER, H; SCOTT, Bart L; SANDMAIER, Brenda M et al.Blood. 2012, Vol 120, Num 7, pp 1398-1408, issn 0006-4971, 11 p.Article

Therapy-related myeloid neoplasms following treatment with radioiodineSCHROEDER, Thomas; KUENDGEN, Andrea; SCHLENK, Richard et al.Haematologica (Roma). 2012, Vol 97, Num 2, pp 206-212, issn 0390-6078, 7 p.Article

¹⁸F-FDG-PET/CT for detection of extramedullary acute myeloid leukemiaSTÖLZEL, Friedrich; RÖLLIG, Christoph; RADKE, Jörgen et al.Haematologica (Roma). 2011, Vol 96, Num 10, pp 1552-1556, issn 0390-6078, 5 p.Article

Mesenchymal stem cells efficiently inhibit the proinflammatory properties of 6-sulfo LacNAc dendritic cellsWEHNER, Rebekka; WEHRUM, Diana; BORNHÄUSER, Martin et al.Haematologica (Roma). 2009, Vol 94, Num 8, pp 1151-1156, issn 0390-6078, 6 p.Article

Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemiaATANACKOVIC, Djordje; LUETKENS, Tim; HEGEWISCH-BECKER, Susanna et al.American journal of hematology. 2011, Vol 86, Num 11, pp 918-922, issn 0361-8609, 5 p.Article

Prophylactic transfer of BCR-ABL―, PR1-, and WT1-reactive donor T cells after T cell―depleted allogeneic hematopoietic cell transplantation in patients with chronic myeloid leukemiaBORNHÄUSER, Martin; THIEDE, Christian; WERMKE, Martin et al.Blood. 2011, Vol 117, Num 26, pp 7174-7184, issn 0006-4971, 11 p.Article

Impact of allogeneic haematopoietic stem cell transplantation in patients with abnl(17p) acute myeloid leukaemiaMOHR, Brigitte; SCHETELIG, Johannes; PLATZBECKER, Uwe et al.British journal of haematology. 2013, Vol 161, Num 2, pp 237-244, issn 0007-1048, 8 p.Article

A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapyLÜBBERT, Michael; RÜTER, Björn H; GALM, Oliver et al.Haematologica (Roma). 2012, Vol 97, Num 3, pp 393-401, issn 0390-6078, 9 p.Article

Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study GroupLÜBBERT, Michael; SUCIU, Stefan; BEELDENS, Filip et al.Journal of clinical oncology. 2011, Vol 29, Num 15, pp 1987-1996, issn 0732-183X, 10 p.Article

Gemtuzumab Ozogamicin as Part of Reduced-Intensity Conditioning for Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed Acute Myeloid LeukemiaBORNHÄUSER, Martin; ILLMER, Thomas; PLATZBECKER, Uwe et al.Clinical cancer research (Print). 2008, Vol 14, Num 17, pp 5585-5593, issn 1078-0432, 9 p.Article

Dose-reduced conditioning and allogeneic hematopoietic stem cell transplantation from Unrelated donors in 42 patientsBORNHÄUSER, Martin; THIEDE, Christian; OELSCHLAGEL, Uta et al.Clinical cancer research. 2001, Vol 7, Num 8, pp 2254-2262, issn 1078-0432Article

Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signalsMOHR, Brigitte; BORNHÄUSER, Martin; PLATZBECKER, Uwe et al.Cancer genetics and cytogenetics. 2001, Vol 127, Num 2, pp 111-117, issn 0165-4608Article

Spleen enlargement in healthy donors during G-CSF mobilization of PBPCsPLATZBECKER, Uwe; PRANGE-KREX, Gabriele; RUTT, Claudia et al.Transfusion (Philadelphia, PA). 2001, Vol 41, Num 2, pp 184-189, issn 0041-1132Article

Clonal Evolution Including Partial Loss of Human Leukocyte Antigen Genes Favoring Extramedullary Acute Myeloid Leukemia Relapse After Matched Related Allogeneic Hematopoietic Stem Cell TransplantationSTÖLZEL, Friedrich; HACKMANN, Karl; ILLMER, Thomas et al.Transplantation. 2012, Vol 93, Num 7, pp 744-749, issn 0041-1337, 6 p.Article

MRI-Based Liver Iron Content Predicts for Nonrelapse Mortality in MDS and AML Patients Undergoing Allogeneic Stem Cell TransplantationWERMKE, Martin; SCHMIDT, Anne; SCHETELIG, Johannes et al.Clinical cancer research (Print). 2012, Vol 18, Num 23, pp 6460-6468, issn 1078-0432, 9 p.Article

Minimal residual disease-directed preemptive treatment with azacitidine in patients with NPM1-mutant acute myeloid leukemia and molecular relapseSOCKEL, Katja; WERMKE, Martin; RADKE, Jörgen et al.Haematologica (Roma). 2011, Vol 96, Num 10, pp 1568-1570, issn 0390-6078, 3 p.Article

¹⁸⁸Re anti-CD66 radioimmunotherapy combined with reduced-intensity conditioning and in-vivo T cell depletion in elderly patients undergoing allogeneic haematopoietic cell transplantationLAUTER, Anett; STRUMPF, Annette; KOTZERKE, Jorg et al.British journal of haematology. 2010, Vol 148, Num 6, pp 910-917, issn 0007-1048, 8 p.Article

Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma : a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom)KNOP, Stefan; GERECKE, Christian; EINSELE, Hermann et al.Blood. 2009, Vol 113, Num 18, pp 4137-4143, issn 0006-4971, 7 p.Article